Intensified Processing for Biopharmaceutical Manufacturing
Technologies That Enable Continuous Production Throughout the Process
Continuous processing in biomanufacturing has the potential to increase production capacity, reduce costs and improve biopharmaceutical product quality. Sartorius Stedim Biotech is collaborating with leading biopharmaceutical companies as they intensify their bioprocesses. With these experiences, we are supporting clients seeking to implement continuous manufacturing operations within their facilities through the provision of technologies, services, insight and expertise.
Making Downstream Processing Continuous and Robust
In a virtual roundtable, BPI has invited several advisors, end users and supplier companies to comment on a discussion on continuous downstream processing. Miriam Monge, Sartorius Stedim Biotech, spoke about how process intensification in upstream has led to an increased footprint in downstream processing amongst other topics.
An Interview on Intensifying Upstream Cell Culture Processes
Watch Dirk Mueller talk about the intensification of upstream cell culture processes. An interview by Miriam Monge at ESACT 2019 in Copenhagen.
Single-Use and Intensified Processing in Commercial Biomanufacturing
BPI TV interviews, Biotech Week 2018, Boston, MA: Miriam Monge and Gerben Zijlstra, Sartorius Stedim Biotech, in discussion with Dan Stanton, Editor of Bioprocess Insider
Bioprocess Intensification - Fast, flexible and efficient solutions
Published as a part of the BioProcess International supplement this compilation of articles details how our experts characterize “process intensification” and how end users can transition toward an increased safety and economic sustainability of continuous processing.
Learn from Our Experts
Interview with Dirk Mueller talking about the intensification of upstream cell culture processes, ESACT 2019.
To develop different types of intensified USP processes, Sartorius offers a toolbox including the ambr® systems as well as cell lines and media. Watch the interview to learn more.
Interview with Gerben Zijlstra on New Tools for Intensified Bioprocessing, ESACT 2019
Continuous processing in biomanufacturing has the potential to increase production capacity, reduce costs and improve biopharmaceutical product quality. View this video to learn more about the tools Sartorius offers and the outstanding product portfolio.